What's in Allgenesis Biotherapeutics Inc.'s pipeline?

Allgenesis Biotherapeutics Inc. has 2 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Allgenesis Biotherapeutics Inc.'s portfolio?

Top competitors by shared drug class: Advagene Biopharma Co. Ltd., Akron Molecules AG, Arcus Biosciences, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/allgenesis-biotherapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Allgenesis Biotherapeutics Inc. — Portfolio Competitive Intelligence Brief

Allgenesis Biotherapeutics Inc. pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Advagene Biopharma Co. Ltd. · 1 shared drug class
Akron Molecules AG · 1 shared drug class
Arcus Biosciences, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Allgenesis Biotherapeutics Inc.:

Cite this brief

Drug Landscape (2026). Allgenesis Biotherapeutics Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/allgenesis-biotherapeutics-inc. Accessed 2026-05-16.